HSE have launched the next phase in the review of Creosote
The AFI have been informed of the following consultation and is willing to help participants with the amount of information’s needed to formulate a submission be that either for its continuation or not.
This is the industries chance to have their say something that went unnoticed during the consultation on CCA so do not miss the opportunity.
If you want to respond and help with the information required please email info@theafi.co.uk with your name, contact details and the way you want to vote so we can send you the relevant information and forms submission.
Under the GB Biocidal Products Regulation (GB BPR), if an active substance meets the exclusion criteria set out in Article 5(1), it would not normally be approved for use in biocidal products in GB.
However, an active substance may still be approved in accordance with Article 5(2) if certain conditions are met.
In these circumstances the active substance may also be considered as a candidate for substitution under Article 10(1) of the GB BPR.
In accordance with Article 10(3), HSE must undertake a consultation on potential candidates for substitution which involves gathering information on the availability, or lack, of suitable and sufficient alternatives.
Creosote has been identified as fulfilling at least one of the exclusion criteria and is a candidate for substitution. A public consultation has now been launched, running until the stated date:
- Creosote (CAS 8001-58-9 EC 232-287-5) in product type 8
24 November 2024. View the consultation and submit comments
It is important that interested parties (manufacturers, users of biocidal products, sectors concerned, authorities etc.) contribute to the consultation to inform the decision-making process, in particular on the availability of suitable alternatives.
Suitable alternatives are substances or technologies that would result in reduced risks (e.g. classification, properties, exposure, use pattern), and which are technically and economically feasible.
We are also interested in information relating to the lack of suitable and sufficient alternatives if you believe none are available.
Recent Comments